Xianglu Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xianglu Li has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Chang‐Xiong Wu
Department of Hepatobiliary and Pancreatic Surgery Hainan General Hospital Haikou City China
1 shared publicationErin E. Mosley
Department of Animal and Veterinary Science (AVS), University of Idaho, Moscow, ID 83844, USA
1 shared publication- Gregory A. Bohach
<!--label omitted: 1-->Department of Microbiology, Molecular Biology and Biochemistry, University of Idaho, Moscow, Idaho 83844,1 and
1 shared publication - Jie Tian
Institute of Electronic Engineering, China Academy of Engineering Physics, Mianyang 621999, China
1 shared publication - Kenneth W. Bayles
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, USA
1 shared publication - Keun Seok Seo
Department of Comparative Biomedical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi State, MS 39762, USA
1 shared publication
Latest Publications
- Open Access
- 24 November 2020
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 37 (4) , 294-304
miR‐188‐5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2
Gallbladder carcinoma (GBC) commonly occurs in gastrointestinal malignancy and has the fifth highest mortality rate among gastrointestinal malignancy. Recently, miR‐188‐5p, a small noncoding RNA, has been implicated in various types of cancer such as nasopharyngeal carcinoma, oral squamous cell carcinoma, liver cancer, and prostate cancer. However, the effect of miR‐188‐5p on GBC remains unclear. Here, we demonstrated that miR‐188‐5p was downregulated in GBC tissues, and downregulation of miR‐188‐5p correlated with larger tumor size, lymph node metastasis, and extensive metastasis. In addition, the overall survival time of patients with higher miR‐188‐5p expression was significantly longer than that of patients with low‐miR‐188‐5p expression. Moreover, downregulation of miR‐188‐5p promoted the proliferation, migration, and invasion of GBC cells, while its overexpression inhibited cell invasion and induced cell apoptosis, and arrested GBC growth in vivo. Importantly, miR‐188‐5p‐dependent tumorigenesis was correlated with Wnt/β‐catenin signaling and p‐38/JNK signaling. In conclusion, miR‐188‐5p plays a direct role in GBC tumorigenesis. Our study suggests that miR‐188‐5p could serve as a novel diagnosis marker and therapeutic target in GBC.
- 24 November 2020
- Published by Wiley in The Kaohsiung Journal of Medical Sciences
- Vol. 37 (4) , 294-304
Open AccessmiR‐188‐5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2
Gallbladder carcinoma (GBC) commonly occurs in gastrointestinal malignancy and has the fifth highest mortality rate among gastrointestinal malignancy. Recently, miR‐188‐5p, a small noncoding RNA, has been implicated in various types of cancer such as nasopharyngeal carcinoma, oral squamous cell carcinoma, liver cancer, and prostate cancer. However, the effect of miR‐188‐5p on GBC remains unclear. Here, we demonstrated that miR‐188‐5p was downregulated in GBC tissues, and downregulation of miR‐188‐5p correlated with larger tumor size, lymph node metastasis, and extensive metastasis. In addition, the overall survival time of patients with higher miR‐188‐5p expression was significantly longer than that of patients with low‐miR‐188‐5p expression. Moreover, downregulation of miR‐188‐5p promoted the proliferation, migration, and invasion of GBC cells, while its overexpression inhibited cell invasion and induced cell apoptosis, and arrested GBC growth in vivo. Importantly, miR‐188‐5p‐dependent tumorigenesis was correlated with Wnt/β‐catenin signaling and p‐38/JNK signaling. In conclusion, miR‐188‐5p plays a direct role in GBC tumorigenesis. Our study suggests that miR‐188‐5p could serve as a novel diagnosis marker and therapeutic target in GBC.
- 21 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
An Improved Closed-Form Solution for Differential RSS-based Localization
One of the advantages of differential received signal strength (DRSS)-based localization is eliminating the dependence of the source transmitted signal power. Therefore, DRSS is able to handle the passive localization as time difference of arrival (TDOA) does. The recent work of [1] investigated a new model for DRSS measurements, but the proposed methods are suboptimal. This paper focuses on the study of localization using DRSS measurements. A new formulation for DRSS localization of a 2-D source is proposed, which leads to a closed-form estimator through minimizing a constrained optimization problem. The solution applies weighted least squares technology only, achieving the Cramér Rao Bound (CRB) accuracy if the noise is mild. A brief analysis validates that the mean-square error (MSE) attains the CRB in the small noise region. The performance and theoretical result are verified by simulations.
- 21 September 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1-5
An Improved Closed-Form Solution for Differential RSS-based Localization
One of the advantages of differential received signal strength (DRSS)-based localization is eliminating the dependence of the source transmitted signal power. Therefore, DRSS is able to handle the passive localization as time difference of arrival (TDOA) does. The recent work of [1] investigated a new model for DRSS measurements, but the proposed methods are suboptimal. This paper focuses on the study of localization using DRSS measurements. A new formulation for DRSS localization of a 2-D source is proposed, which leads to a closed-form estimator through minimizing a constrained optimization problem. The solution applies weighted least squares technology only, achieving the Cramér Rao Bound (CRB) accuracy if the noise is mild. A brief analysis validates that the mean-square error (MSE) attains the CRB in the small noise region. The performance and theoretical result are verified by simulations.
- 1 July 2020
- Published by Springer Nature in Human Cell
- Vol. 33 (4) , 1165-1175
miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer
Pancreatic cancer is a malignant disease with poor prognosis. Emerging evidences have showed that miR-597-5p is closely related to tumor development. However, the functional roles of miR-597-5p in pancreatic cancer remain unknown. This study aimed to investigate the expression of miR-597-5p in pancreatic cancer tissues and cells, and explored its regulatory mechanism during pancreatic cancer progression. Pancreatic cancer and adjacent tissues were obtained to detect the expression of miR-597-5p by RT-qPCR. Cell growth, apoptosis, and related protein expression were, respectively, tested by CCK-8 assay, cell formation, wound healing, Transwell assay, flow cytometry, and western blotting. Finally, the pancreatic cancer mice model was constructed. In vitro and in vivo results showed that miR-597-5p expression was down-regulated in pancreatic cancer tissues and cell lines, and increased the overall survival of pancreatic cancer patients. Moreover, miR-597-5p decreased pancreatic cancer cell viability, reduced relative wound width, suppressed colony formation and decreased invasive cell number, as well as reduced the expression of proliferating cell nuclear antigen (PCNA), Ki67, Cyclin D1, N-cad, and Bcl-2. Meanwhile, it increased pancreatic cancer cell apoptosis and the expression of E-cad, cleaved caspase 3, and Bax. The dual-luciferase reporter assay confirmed miR-597-5p could directly target e-twenty six like-1 (ELK1) oncogene. The reduction of cell growth and the induction of cell apoptosis induced by miR-597-5p were reversed by ELK1. In addition, miR-597-5p inhibited the growth of pancreatic cancer in vivo. This study demonstrated that miR-597-5p may be a novel suppressor of pancreatic cancer. It inhibits pancreatic cancer cell growth and promotes apoptosis by the down-regulation of ELK1 in vitro and in vivo.
- 1 July 2020
- Published by Springer Nature in Human Cell
- Vol. 33 (4) , 1165-1175
miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer
Pancreatic cancer is a malignant disease with poor prognosis. Emerging evidences have showed that miR-597-5p is closely related to tumor development. However, the functional roles of miR-597-5p in pancreatic cancer remain unknown. This study aimed to investigate the expression of miR-597-5p in pancreatic cancer tissues and cells, and explored its regulatory mechanism during pancreatic cancer progression. Pancreatic cancer and adjacent tissues were obtained to detect the expression of miR-597-5p by RT-qPCR. Cell growth, apoptosis, and related protein expression were, respectively, tested by CCK-8 assay, cell formation, wound healing, Transwell assay, flow cytometry, and western blotting. Finally, the pancreatic cancer mice model was constructed. In vitro and in vivo results showed that miR-597-5p expression was down-regulated in pancreatic cancer tissues and cell lines, and increased the overall survival of pancreatic cancer patients. Moreover, miR-597-5p decreased pancreatic cancer cell viability, reduced relative wound width, suppressed colony formation and decreased invasive cell number, as well as reduced the expression of proliferating cell nuclear antigen (PCNA), Ki67, Cyclin D1, N-cad, and Bcl-2. Meanwhile, it increased pancreatic cancer cell apoptosis and the expression of E-cad, cleaved caspase 3, and Bax. The dual-luciferase reporter assay confirmed miR-597-5p could directly target e-twenty six like-1 (ELK1) oncogene. The reduction of cell growth and the induction of cell apoptosis induced by miR-597-5p were reversed by ELK1. In addition, miR-597-5p inhibited the growth of pancreatic cancer in vivo. This study demonstrated that miR-597-5p may be a novel suppressor of pancreatic cancer. It inhibits pancreatic cancer cell growth and promotes apoptosis by the down-regulation of ELK1 in vitro and in vivo.
- Open Access
- 1 January 2009
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2009, 1-11
Epithelial Cell Gene Expression Induced by IntracellularStaphylococcus aureus
HEp-2 cell monolayers were cocultured with intracellularStaphylococcus aureus, and changes in gene expression were profiled using DNA microarrays. IntracellularS. aureusaffected genes involved in cellular stress responses, signal transduction, inflammation, apoptosis, fibrosis, and cholesterol biosynthesis. Transcription of stress response and signal transduction-related genes includingatf3, sgk, map2k1, map2k3, arhb, andarhewas increased. In addition, elevated transcription of proinflammatory genes was observed fortnfa, il1b, il6, il8, cxcl1, ccl20, cox2,andpai1. Genes involved in proapoptosis and fibrosis were also affected at transcriptional level by intracellularS. aureus. Notably, intracellularS. aureusinduced strong transcriptional down-regulation of several cholesterol biosynthesis genes. These results suggest that epithelial cells respond to intracellularS. aureusby inducing genes affecting immunity and in repairing damage caused by the organism, and are consistent with the possibility that the organism exploits an intracellular environment to subvert host immunity and promote colonization.
- 1 January 2009
- Published by Hindawi Limited in International Journal of Microbiology
- Vol. 2009, 1-11
Open AccessEpithelial Cell Gene Expression Induced by IntracellularStaphylococcus aureus
HEp-2 cell monolayers were cocultured with intracellularStaphylococcus aureus, and changes in gene expression were profiled using DNA microarrays. IntracellularS. aureusaffected genes involved in cellular stress responses, signal transduction, inflammation, apoptosis, fibrosis, and cholesterol biosynthesis. Transcription of stress response and signal transduction-related genes includingatf3, sgk, map2k1, map2k3, arhb, andarhewas increased. In addition, elevated transcription of proinflammatory genes was observed fortnfa, il1b, il6, il8, cxcl1, ccl20, cox2,andpai1. Genes involved in proapoptosis and fibrosis were also affected at transcriptional level by intracellularS. aureus. Notably, intracellularS. aureusinduced strong transcriptional down-regulation of several cholesterol biosynthesis genes. These results suggest that epithelial cells respond to intracellularS. aureusby inducing genes affecting immunity and in repairing damage caused by the organism, and are consistent with the possibility that the organism exploits an intracellular environment to subvert host immunity and promote colonization.